MedaM, VirgincarN, GentryV, et al.Clostridium difficile infection in pregnant and postpartum women in 2 hospitals and a review of literature. Am J Infect Control, 2019; 47:e7–e14.
2.
VenugopalAA, GerdingDN, JohnsonS. Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolates. Am J Infect Control, 2011; 39:206–211.
3.
KellyCR, FischerM, AllegrettiJR, et al.ACG Clinical Guidelines: Prevention, diagnosis, and treatment of Clostridioides difficile infections. Am J Gastroenterol, 2021; 116:1124–1147.
4.
JohnsonS, LavergneV, SkinnerAM, et al.Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis, 2021; 73:e1029–e1044.
5.
Anon. Treatment of Clostridioides difficile infection. Med Lett Drugs Ther, 2021; 63:137–141.
6.
ReyesMP, OstreaEMJr, CabinianAE, et al.Vancomycin during pregnancy: Does it cause hearing loss or nephrotoxicity in the infant?. Am J Obstet Gynecol, 1989; 161:977–981.
7.
AndersonPO. Monoclonal antibodies during breastfeeding. Breastfeed Med, 2021; 16:591–593.
